Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

e-Counseling Promotes Blood Pressure Reduction and Therapeutic Lifestyle Change in Hypertension

Not Applicable

Completed

Conditions: Hypertension

Interventions: Behavioral: e-Counseling plus Usual Care
Behavioral: Control

First Posted Date: 2012-03-01

Last Posted Date: 2016-10-07

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 264

Registration Number: NCT01541540

Locations: 🇨🇦
Vancouver Coastal Health, Vancouver, British Columbia, Canada
🇨🇦
London Health Science Center, London, Ontario, Canada
🇨🇦
Grey Bruce Health Unit, Owen Sound, Ontario, Canada

and more 1 locations

Personalizing Health Outcome in Epilepsy Now - An Introduction to Clinical Services

Not Applicable

Conditions: Medically Intractable Epilepsy

Interventions: Behavioral: Andrews/Reiter approach to epilepsy
Behavioral: Relaxation/Meditation

First Posted Date: 2012-02-15

Last Posted Date: 2012-02-15

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 30

Registration Number: NCT01533649

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)

Phase 2

Completed

Conditions: Chronic Lymphocytic Leukemia (CLL)

Interventions: Drug: Ofatumumab with GSK2110183

First Posted Date: 2012-02-14

Last Posted Date: 2019-09-24

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 28

Registration Number: NCT01532700

Locations: 🇨🇦
University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada

Revatio Portal-Pulmonary Arterial Hypertension Trial

Phase 2

Terminated

Conditions: Portopulmonary Hypertension

Interventions: Drug: Placebo
Drug: Sildenafil

First Posted Date: 2012-01-25

Last Posted Date: 2019-09-27

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 12

Registration Number: NCT01517854

Locations: 🇨🇦
Lawson Health Research Institute (London Health Sciences Centre Research Inc.), London, Ontario, Canada
🇨🇦
Institut universitaire de cardiologie et de pneumologie de Québec, Québec, Canada
🇨🇦
University Health Network, Toronto, Ontario, Canada

Electrical Interactions in Heart Disease

Conditions: Cardiomyopathy, Dilated

Interventions: Other: Observational study, no intervention

First Posted Date: 2012-01-12

Last Posted Date: 2012-01-12

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100

Registration Number: NCT01508871

Locations: 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada

Telephone-based Cognitive Behavioral Therapy for Bariatric Surgery Patients: A Pilot Study

Not Applicable

Completed

Conditions: Obesity
Eating Disorder

Interventions: Behavioral: Telephone Based Cognitive Behavioral Therapy

First Posted Date: 2012-01-12

Last Posted Date: 2015-07-16

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 47

Registration Number: NCT01508585

Managing Cancer and Living Meaningfully (CALM): A Study to Evaluate the Effectiveness of a Psychological Intervention for Cancer Patients

Phase 3

Completed

Conditions: Depression

Interventions: Behavioral: CALM

First Posted Date: 2012-01-10

Last Posted Date: 2019-09-27

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 305

Registration Number: NCT01506492

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Integrated Molecular Profiling in Advanced Cancers Trial

Active, not recruiting

Conditions: Gynecological Cancers
Genitourinary Cancer
Pancreatobiliary Gastrointestinal Cancer
Upper Aerodigestive Tract Cancer
Non-small Cell Lung Cancer
Colorectal Cancer
Melanoma Cancers
Rare Cancers
Breast Cancer
Unknown Primary Cancers

First Posted Date: 2012-01-06

Last Posted Date: 2025-02-03

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 3026

Registration Number: NCT01505400

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

Unrecognised Obstructive Sleep Apnea Study

Completed

Conditions: Obstructive Sleep Apnea

First Posted Date: 2011-12-16

Last Posted Date: 2018-01-29

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 1200

Registration Number: NCT01494181

Locations: 🇸🇬
Khoo Teck Puat Hospital, Singapore, Singapore
🇭🇰
Prince of Wales Hospital, Shatin, Hong Kong
🇲🇾
Unversity Malaya Medical Centre, Kuala Lumpur, Malaysia

and more 1 locations

Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer

Recruiting

Conditions: Lung Cancer

First Posted Date: 2011-12-07

Last Posted Date: 2024-07-16

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 400

Registration Number: NCT01487603

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy